 SUNNYVALE, Calif., Feb. 25, 2022 GLOBE NEWSWIRE -- 23andMe Holding Co. Nasdaq: ME 23andMe, a leading consumer genetics and research company with a mission to help people access, understand, and benefit from the human genome, announced today that management will be presenting at the Cowen 42nd Annual Health Care Conference on March 7, 2022 at 2:50 p.m. Eastern Time. 